Literature DB >> 7838037

Survival after retinoblastoma: long-term consequences and family history of cancer.

J Byrne1, T R Fears, C Whitney, D M Parry.   

Abstract

Retinoblastoma (Rb) is a rare childhood tumor of the eye. In the heritable form, tumors are often bilateral and survivors have a greatly increased risk both for a second malignancy and for having children with Rb. Familial patterns of both cancer and birth defects are poorly understood in families with a heritable cancer, and little is known of the ways that a heritable cancer affects the lives of long-term survivors. To find out more about these and other issues in the lives of long-term survivors of childhood and adolescent cancer, we interviewed 56 adult survivors of retinoblastoma (15 with the heritable form) and 84 brothers and sisters as controls, who formed part of a large retrospective cohort study. Rb survivors were interviewed between 1980 and 1983, when they were 30 years old on average. Types of employment and health problems did not differ between survivors and controls, regardless of sight, but the income of blind survivors was considerably less than that of partially sighted survivors. Despite similar marriage rates, fewer survivors than controls reported a pregnancy (RR = 0.45; 95% CI; 0.24-0.83 for both sexes combined). Parents of children with heritable Rb seemed more likely to have had cancer than parents in families with nonheritable Rb (P = 0.06), and mothers were more likely than fathers to be affected (P = 0.01). This small series suggests that having retinoblastoma may have many long-term consequences, reaching beyond genetic and physical effects to touch family life and income attainment and the health of other family members. Follow-up of more modern cohorts and the use of molecular tools will clarify the long-term consequences of more recent therapies, and patterns of familiar cancer.

Entities:  

Mesh:

Year:  1995        PMID: 7838037     DOI: 10.1002/mpo.2950240304

Source DB:  PubMed          Journal:  Med Pediatr Oncol        ISSN: 0098-1532


  9 in total

1.  Metastatic and nonmetastatic models of retinoblastoma.

Authors:  P Chévez-Barrios; M Y Hurwitz; K Louie; K T Marcus; V N Holcombe; P Schafer; C E Aguilar-Cordova; R L Hurwitz
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

2.  Immunohistochemical expression of CD117 and vascular endothelial growth factor in retinoblastoma: possible targets of new therapies.

Authors:  Nermeen S Youssef; Azza M Said
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

3.  Knowledge, experiences and attitudes concerning genetics among retinoblastoma survivors and parents.

Authors:  Jessica A Hill; Amal Gedleh; Siwon Lee; Kaitlyn A Hougham; Helen Dimaras
Journal:  Eur J Hum Genet       Date:  2018-01-29       Impact factor: 4.246

4.  C1q nephropathy in a child with a chromosome 13 deletion.

Authors:  Isabel Roberti; Sachin Sachdev; Adam Aronsky; Dae Un Kim
Journal:  Pediatr Nephrol       Date:  2006-03-07       Impact factor: 3.714

5.  Antitumor activity of celastrol nanoparticles in a xenograft retinoblastoma tumor model.

Authors:  Zhanrong Li; Xianghua Wu; Jingguo Li; Lin Yao; Limei Sun; Yingying Shi; Wenxin Zhang; Jianxian Lin; Dan Liang; Yongping Li
Journal:  Int J Nanomedicine       Date:  2012-05-09

6.  Retinoblastoma: teacher of cancer biology and medicine.

Authors:  Alfred Knudson
Journal:  PLoS Med       Date:  2005-10-25       Impact factor: 11.069

7.  Quality of life of adult retinoblastoma survivors in the Netherlands.

Authors:  Jennifer van Dijk; Saskia M Imhof; Annette C Moll; Peter J Ringens; Peggy T Cohen-Kettenis; Frank Rijmen; Jaap Huisman
Journal:  Health Qual Life Outcomes       Date:  2007-06-04       Impact factor: 3.186

8.  Income in Adult Survivors of Childhood Cancer.

Authors:  Laura Wengenroth; Grit Sommer; Matthias Schindler; Ben D Spycher; Nicolas X von der Weid; Eveline Stutz-Grunder; Gisela Michel; Claudia E Kuehni
Journal:  PLoS One       Date:  2016-05-23       Impact factor: 3.240

Review 9.  Primary osteosarcoma of frontal bone: A case report and review of literature.

Authors:  Guangyong Wu; Qi Liang; Yu Liu
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.